Plus Minus Chat Login Arrow right Chevron left Chevron right Close Close circle Lock Apple Windows Compare Arrow Up Right Book Lightning Flag Arrow Right Chart Bar Wavy Circle Check Cube Envelope Graduation Cap Info Link List Numbers List Pencil Line Star Table Profile Youtube Twitter Facebook LinkedIn Google Plus Box Speech Bubble Television Icon Arrow Circle Right Search Lightbulb Link Out Select Arrows Apple Podcasts Spotify Google Podcasts Amazon Music

Applications Open for International Prize Recognising Women Scientists in MS


min read
 
 
Submissions for the ECTRIMS’ supported “Rachel Horne Prize for Women’s Research in MS ” are now open.
 
This US$40,000 annual award – a new international endeavour launched last year at #ECTRIMS2022 – recognises a woman scientist for their outstanding contribution to women’s health-related research in multiple sclerosis.
 
The award will be given to a selected woman scientist for her work in furthering the understanding of women’s health issues and treatment strategies in MS, and announced on 11-13 October at #MSMilan2023.
 
You may submit your nominations via the Rachel Horne website’s online application portal.

*About the Prize

The Prize is intended for mid-to-senior career women MS scientists and neurologists. Applicants must have worked for more than 15 years at Assistant Professor level and, at the time of application, hold the title of Associate Professor or Professor. Applicants should identify as female. There are no specific requirements in respect of residency or citizenship.

Applications are to be submitted online by the applicant and should include a CV. A Letter of Recommendation will also be required by a referee, describing why the applicant is suitable for the prize.  Full details of the application process can be found by registering on the online application portal. The deadline for submitting applications is 9 June 2023.

The review panel will include members of International Women in MS. The winner will be announced in September and the award made at the 9th Joint ECTRIMS-ACTRIMS meeting in Milan, Italy in October 2023.

The Rachel Horne Prize for Women’s Research in MS is to be used at the discretion of the recipient. It is made possible by the generosity of the Horne Family Charitable Foundation and is supported by International Women in MS (iWiMS) and the European Committee for Treatment and Research in Multiple Sclerosis (ETRIMS).

“iWiMS is delighted to partner with the Rachel Horne Prize for Women’s Research in MS in  recognising the important research women neuroscientists conduct into the distinct health needs of women with MS,” says Professor Emmanuelle Waubant, Chair of iWiMS. “For too long, women have been overlooked when it comes to rewarding their research into MS and the particular issues facing women with MS are often given insufficient attention. 

About Rachel Horne

Rachel Horne was diagnosed with multiple sclerosis in 2009. Drawing on her journalism background, she began researching the disease from a patient perspective and realised how little information existed about specific women’s health issues in MS – even though women make up two thirds of the people diagnosed with the disease.

She was also struck by how few women neurologists and scientists in MS were recognised for their research. In response, she set up the Rachel Horne Prize for Women’s Research in MS through the Horne Family Charitable Foundation in Canada which was established by her father in 2010 “to do good in the world”.

About the Horne Family Charitable Foundation

This prize, made possible by the generosity of the Horne Family Charitable Foundation, is to be used at the discretion of the recipient.

The Horne family believes in the importance of philanthropy to shape our world. It was this belief which led Stuart Horne to set up the Horne Family Charitable Foundation following his death in 2010. The family foundation is administered by Aqueduct Foundation, which is based in Vancouver, Canada. It grants to education, the environment, humanitarian and medical causes.

*Excerpt taken from Rachel Horne Press Release